COMMUNIQUÉS West-GlobeNewswire

pSivida to Present at the 2018 BIO CEO & Investor Conference
09/02/2018
WATERTOWN, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug products and technologies, announced today that Nancy Lurker, President [...]
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2017
09/02/2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]
Novo Nordisk A/S: Ozempic® (semaglutide) approved in the EU for the treatment of type 2 diabetes
09/02/2018
Bagsværd, Denmark, 9 February 2018 - Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation for Ozempic ® (semaglutide) for the treatment of adults with type 2 diabetes. [...]
Achillion to Present at the Leerink Partners 7th Annual Global Healthcare Conference
09/02/2018
NEW HAVEN, Conn., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN ) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will participate in a [...]
ContraVir Pharmaceuticals to Present at BIO CEO & Investor Conference
09/02/2018
EDISON, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]
Calithera to Participate in Leerink Partners 7th Annual Global Healthcare Conference
09/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today announced [...]
Ambu A/S: Articles of Association February 2018
09/02/2018
Articles of Association February 2018 Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/ef9a3672-1646-4832-92e3-9680a37d2a9a
Ambu A/S: Capital increase in connection with exercise of warrants
09/02/2018
In December 2014, Ambu A/S issued 2,000,000 warrants, each warrant entitling the holder to subscribe for one Class B share with a nominal value of DKK 0.50. These warrants were issued to 22 employees with a vesting [...]
BioPorto and Roche Diagnostics sign a distribution agreement for NGAL
09/02/2018
BioPorto A/S (“BioPorto”) has entered into a global distribution agreement with Roche, under which BioPorto will deliver a neutrophil gelatinase-associated lipocalin (NGAL) test for use on Roche’s cobas c 501/c 502 [...]
CellaVision AB Year-end Bulletin 2017
09/02/2018
Stable quarter with continued strategic initiatives October 1 - December 31, 2017 Net sales increased by 5 percent to SEK 76.1 million (72.8). Organic growth was 6 % (14). Operating profit increased to SEK 21.7 million [...]
NeuroSearch A/S releasing Annual Report 2017
09/02/2018
Announcement no. 1-18 Page 1 of 2 Company announcement 9 February 2018 The full version of the Annual Report 2017 for NeuroSearch is available in the enclosed PDF file. In 2017, NeuroSearch (NEUR) realised an operating [...]
iTeos Therapeutics to Present New Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at Molecular Medicine Tri-Conference
09/02/2018
iTeos Therapeutics to Present New Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at Molecular Medicine Tri-Conference Two Phase 1 trials to start in 2018 for A 2A receptor antagonist and [...]
NeuroSearch A/S releasing Annual Report 2017
09/02/2018
Announcement no. 1-18 Page 1 of 2 Company announcement 9 February 2018 The full version of the Annual Report 2017 for NeuroSearch is available in the enclosed PDF file. In 2017, NeuroSearch (NEUR) realised an operating [...]
Outcome from DSMB Safety Review and Extension of TACTI-mel Phase I Clinical Trial
09/02/2018
SYDNEY, Australia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (“Immutep” or the “Company”), announced today that the Database Safety Monitoring Board (“DSMB”) confirmed that the [...]
Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore
09/02/2018
MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB ) announced today that the U.S. International Trade Commission (the “ITC”) has terminated its investigation [...]
miRagen Therapeutics, Inc. Prices Public Offering of Common Stock
09/02/2018
BOULDER, Colo., Feb. 08, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today [...]
FDA Grants Orphan Drug Designation (ODD) for Xeris Pharmaceuticals' Ready-to-Use Glucagon for the Treatment of Hyperinsulinemic Hypoglycemia (HH). Results from Phase 2a Study in Post-Bariatric Hypoglycemia, Associated with HH, Published.
09/02/2018
Chicago, IL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]
Aclaris Therapeutics to Present Data on ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) at the 2018 American Academy of Dermatology Annual Meeting
08/02/2018
ESKATA™ received FDA approval for the treatment of raised seborrheic keratoses (SKs) in December 2017 WAYNE, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led [...]
Accelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February 15, 2018
08/02/2018
TUCSON, Ariz., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. will host a conference call on Thursday, February 15, 2018 to review its fourth quarter and full-year financial results for 2017. President [...]

Pages